Year: 2025
Type: article
Abstract: The definition of health priorities, with finite resources but growing needs, requires quantitative instruments, public involvement, and multi-criteria. These frameworks include the impact on the burden of disease for informed and transparent governance. Among the methods available, Programme Budgeting and Marginal Analysis (PBMA) stands out for its ability to guide decisions with a strong economic basis. This is based on a budgetary analysis, but also on the budget impact of interventions or policies that necessarily use the burden of disease for this analysis. To enable change and improve health, it is essential to understand the impact that any intervention or policy will have on the target population and at a macro level on population health, which can be done through metrics such as DALYs. However, the economic rationale for marginal analysis and consideration of opportunity costs is essential. Nevertheless, it is also necessary to consider the trade-off between efficiency and equity. And this is where the main disadvantage of using only the burden of disease emerges. There should be no competition between diseases by their level of prevalence, considering rare diseases to be less critical, even though their magnitude is one of the possible points of prioritisation in health. In this workshop, we will explore how the burden of disease can be integrated into PBMA processes and how quantitative frameworks can inform health policies.
Author: J Santos
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $3,181
OpenAlex ID: W7101413542
FWCI:
Cites:
Cited by:
Related to: